BRCA1 and cancer: Variants whose impact on function cannot be directly inferred by the genetic code are categorized as VUS and are evaluated by multifactorial likelihood models that use personal and family history of cancer, segregation data, prediction tools, and co-occurrence with a pathogenic BRCA1 variant [58,59,64].